SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS/soon to below 20

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MIKE DUBIS who wrote (4)12/9/1997 1:33:00 AM
From: BDR  Read Replies (3) of 40
 
The preference of new impotence patients in my practice used to be for MUSE by a wide margin (about 90%) but since the cover story in the news weekly the first choice is now "do nothing and wait until the FDA approves the pill" ( > 50%) and MUSE is second at something less than 40%. This shift in patient preference has got to show up on the VVUS income statement one of these quarters, even if Viagra isn't all it is cracked up to be.

Formerly short (profitably), battered into silence by the longs on the "old" thread and now holding no position in VVUS.

Regards.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext